TAI · 6782.TW
Visco Vision Inc.
NT$264.00-NT$5.00 (-1.86%)
Visco Vision Inc.’s quoted price sits in the upper half of its reported 52-week range, 4.0% below the high.
Loading market information…
TAI · 4104.TW · TWD
Stock price, dividends, earnings
Quote as of Oct 30, 2026, 05:30 AM UTC. Cached market data; not a live quote.
One-year closing-price history · TWD. Historical prices are not a forecast.
Excelsior Medical Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 14.84% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Excelsior Medical Co., Ltd.’s forward annual dividend is NT$4.30 per share, paid annual. The forward yield is 5.9% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
Excelsior Medical Co., Ltd.’s next earnings report is currently expected on Nov 6, 2026. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow Excelsior Medical Co., Ltd.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Excelsior Medical Co., Ltd. operates as a distributor of a diverse range of healthcare technology and products throughout various Asian nations, specifically Taiwan, mainland China, Japan, South Korea, Malaysia, and the Philippines. Its extensive portfolio encompasses specialized machinery for hemodialysis, routine pharmaceuticals for healthcare facilities, surgical instrumentation, and electronic aids for medical professionals, in addition to cosmetic devices. The company further extends its services to offer administrative support tailored for individual medical departments. Established in 1988, Excelsior Medical maintains its headquarters in New Taipei City, Taiwan.
Latest available per-share figures in TWD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 10:50 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
| NT$2.16B0.0% vs estimate |
| Q4 2024 | Mar 7, 2025 | NT$1.17-2.5% vs estimate | NT$2.28B-0.96% vs estimate |
|---|
| Q3 2024 | Nov 8, 2024 | NT$0.93-24.39% vs estimate | NT$2.06B-8.48% vs estimate |
|---|
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
NT$264.00-NT$5.00 (-1.86%)
Visco Vision Inc.’s quoted price sits in the upper half of its reported 52-week range, 4.0% below the high.
NT$59.70-NT$0.10 (-0.17%)
YungShin Global Holding Corporation’s quoted price sits in the upper half of its reported 52-week range, 3.71% below the high.
NT$28.80-NT$0.15 (-0.52%)
Synmosa Biopharma Corporation’s quoted price sits in the lower half of its reported 52-week range, 8.54% below the high.
NT$150.50-NT$2.00 (-1.31%)
Ever Supreme Bio Technology Co., Ltd’s quoted price sits in the lower half of its reported 52-week range, 18.21% below the high.
NT$131.00-NT$1.50 (-1.13%)
TaiDoc Technology Corporation’s quoted price sits in the upper half of its reported 52-week range, 5.07% below the high.
NT$129.50-NT$1.50 (-1.15%)
Universal Vision Biotechnology Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 19.57% below the high.
NT$62.60-NT$1.50 (-2.34%)
Great Tree Pharmacy Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 44.6% below the high.
NT$28.50-NT$1.40 (-4.68%)
Tanvex BioPharma, Inc.’s quoted price sits in the lower half of its reported 52-week range, 56.49% below the high.
